Semaglutide
6.000,00 EGP
GLP-1 receptor agonist. Clinically proven 10-15% body-weight reduction.
Description
What It Is
Semaglutide is a GLP-1 receptor agonist for effective weight management and blood sugar control, clinically proven for sustained fat loss. It is the active ingredient in Ozempic and Wegovy.
Best For
- Weight loss and obesity management
- Type 2 diabetes or prediabetes
- Patients new to GLP-1 therapy
Key Benefits
- Clinically proven 10β15% body-weight reduction
- Improves blood sugar control
- Reduces appetite and cravings
- Once-weekly dosing
Dosage Protocol
Beginner: 0.25 mg once weekly for 4 weeks
Common: 0.5β1 mg once weekly
Advanced: 2 mg once weekly
Included With Every Order
β Reconstitution solution, reconstitution syringe, and administration syringes included.

